Villoglandular adenocarcinoma of the cervix: Two new cases with morphological and molecular study

International Journal of Gynecological Pathology

Volumn 26, Issue 2, 2007, Pages 199-204

  Giordano, Giovanna ^a   D'Adda, Tizsiana ^a   Gnetti, Letizia ^a   Merisio, Carla ^a   Gabrielli, Marzio ^a   Melpignano, Mauro ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Cervix; Polymerase chain reaction; Villoglandular adenocarcinoma

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DNA; ESTROGEN; KERATIN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE RECEPTOR; PROTEIN P16INK4A; PROTEIN P53; VIMENTIN;

ADENOCARCINOMA; ADULT; ARTICLE; CASE REPORT; FEMALE; GENE AMPLIFICATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; MORPHOLOGY; ORAL CONTRACEPTION; PAPILLARY CARCINOMA; PATHOGENESIS; PATHOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOKING; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADENOCARCINOMA; ADULT; ANTIBODIES, NEOPLASM; CA-125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATIN-7; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 34147137864     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000228141.01964.e7     Document Type: Article

References (30)

1. Young RH, Scully RE. Villoglandular adenocarcinoma of the uterine cervix. Cancer 1989;63:1773-9.
2. Scully RE, Bonfiglio TA, Kurman RJ, et al. Histological typing of female genital tract tumors. World Health Organization International Histological Classification of Tumors, 2nd ed. NY: Springer-Verlag, 1994:44.
3. Yamazawa K, Matsui H, Seki K, et al. Human papillomavirus-positive well-differentiated villoglandular adenocarcinoma of the uterine cervix: a case report and review of the literature. Gynecol Oncol 2000;77(3):473-7.
4. Kaku T, Kamura T, Shigematsu T, et al. Adenocarcinoma of the uterine cervix with predominantly villoglandular growth pattern. Gynecol Oncol 1997;64:153-5.
5. Costa MJ, Mcllnay KR, Trelfor J. Cervical carcinoma with glandular differentiation: histological evaluation predict disease recurrence in clinical stage I or II patients. Hum Pathol 1995;26:829-37.
6. Hopson L, Jones MA, Boyce CR, et al. Papillary villoglandular carcinoma of the cervix. Gynecol Oncol 1990;39:221-4.
7. Jones MW, Silverberg SG, Kurman RJ. Well differentiated villoglandular adenocarcinoma of the uterine cervix: a clinicopathological study of 24 cases. Int J Gynecol Pathol 1993;12:1-7.
8. de Roda Husman AM, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
9. Greer CE, Peterson SL, Kiviat NB, et al. PCR amplification from paraffin-embedded tissues: effects of fixative and fixation time. Am J Clin Pathol 1991;95:117-24.
10. Nicoll JAR, Love S, Burton PA, et al. Autopsy findings in two cases of neonatal herpes simplex virus infection: detection of virus by immunohistochemistry, in situ hybridization and the polymerase chain reaction. Histopathology 1994;24:257-64.
11. Khunamornpong S, Maleemonkol S, Siriaunkgul S, et al. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a report of 15 cases including two with lymph node metastasis. J Med Assoc Thai 2001;84(6):882-8.
12. Garcea A, Nunns D, Ireland D, et al. A case of villoglandular papillary adenocarcinoma of the cervix with lymph node metastasis. BJOG 2003;110(6):627-9.
13. Utsugi K, Shimizu Y, Akiyama F, et al. Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix. Gynecol Oncol 2004;92(1):64-70.
14. Dede M, Deveci G, Deveci MS, et al. Villoglandular papillary adenocarcinoma of the uterine cervix in a pregnant woman: a case report and review of literature. Tohoku J Exp Med 2004;202(4):305-10.
15. Bouman A, Oosterhuis GJ, Naudin ten Cate L, et al. Villoglandular papillary adenocarcinoma of the cervix. Beware of a wolf in sheep's clothing. Eur J Obstet Gynecol Reprod Biol 1999;87(2):183-9.
16. Polat A, Dusmez D, Pata O, et al. Villoglandular papillary adenocarcinoma of the uterine cervix with immunohistochemical characteristics. J Exp Clin Cancer Res 2002;21(3):425-7.
17. Jones MW, Kounelis S, Papadaki H, et al. Well-differentiated villoglandular adenocarcinoma of the uterine cervix oncogene/tumor suppressor gene alterations and human papillomavirus genotyping. Int J Gynecol Pathol 2000;19(2):110-7.
18. Matthews-Greer J, Dominguez-Malagon H, Herrera GA, et al. Human papillomavirus typing of rare cervical carcinomas. Arch Pathol Lab Med 2004;128(5):553-6.
19. Wright TC, Ferenczy A. Benign disease of the cervix. In: Kurman RJ ed. Blaustein's Pathology of the Female Genital Tract. NY: Springer-Verlag, 2002:225-52.
20. Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumors of the cervix. In: Kurman RJ ed. Blaustein's Pathology of the Female Genital Tract. NY: Springer-Verlag, 2002:325-81.
21. Scharl A, Crombach G, Vierbuchen M, et al. Ca 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube Immunohistochemical detection. Arch Gynecol Obstet 1989;244:103-12.
22. Alkushi A, Irving J, Hsu F, et al. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch 2003;442(3):271-7.
23. Smedts F, Ramaekers F, Troyanovsky S, et al. Keratin expression in cervical cancer. Am J Pathol 1992;141:497-511.
24. McCluggage WG, Sumathi VP, McBride HA, et al. A panel of immunohistochemical stains, including carcinoembryonic antigen, endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 2002;21:11-5.
25. McCluggage WG, Jenkins D. P16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 2003;22:231-5.
26. Delvenne P, Fontaine MA, Delvenne C, et al. Detection of human papillomaviruses in paraffin-embedded biopsies of cervical intraepithelial lesions: analysis by immunohistochemistry, in situ hybridization, and the polymerase chain reaction. Mod Pathol 1994;7(1):113-9.
27. Sano T, Oyama T, Kashiwabara K, et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998;153(6):1741-8.
28. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92(2):276-84.
29. Matos A, Moutinho J, Pinto D, et al. The influence of smoking and other cofactors on the time to onset to cervical cancer in a southern European population. Eur J Cancer Prev 2005;14(5):485-91.
30. Madeleine MM, Daling JR, Schwartz SM, et al. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomarkers Prev 2001;10(3):171-7.